TFAP2A and branchiooculofacial syndrome: Recently, a de novo heterozygous inversion disrupting the TFAP2A TAD was also identified in a patient with branchiooculofacial syndrome (BOFS; branchial cleft, ocular anomalies, facial dysmorphisms) (Fig. 3j)114.